Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 3 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 2,499 business days late.
The 9 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Oct 14, 2025 | LVTX | LAVA Therapeutics NV | SSELL | 227,341 | $1.51 | $343.3K | -4.3% | Open the original filing on SEC.gov |
| Oct 13, 2025 | LVTX | LAVA Therapeutics NV | SSELL | 47,686 | $1.54 | $73.4K | -0.9% | Open the original filing on SEC.gov |
| Oct 10, 2025 | LVTX | LAVA Therapeutics NV | SSELL | 49,869 | $1.55 | $77.3K | -0.9% | Open the original filing on SEC.gov |
| Oct 9, 2025 | LVTX | LAVA Therapeutics NV | SSELL | 48,169 | $1.56 | $75.1K | -0.9% | Open the original filing on SEC.gov |
| Oct 8, 2025 | LVTX | LAVA Therapeutics NV | SSELL | 28,954 | $1.57 | $45.5K | -0.5% | Open the original filing on SEC.gov |
| Oct 20, 2015 | LVTX | LAVA Therapeutics NV | SSELL | 1M | $1.46 | $1.5M | -33.9% | Open the original filing on SEC.gov |
| Oct 15, 2015 | LVTX | LAVA Therapeutics NV | SSELL | 200,000 | $1.51 | $302K | -4.0% | Open the original filing on SEC.gov |